Roche doesn't need M&A to boost sales, sees growth from own meds - (NASDAQ via NewsPoints Desk)

  • Roche CEO Severin Schwan said the company expects its current pipeline to provide growth in the long term, as reported NASDAQ Friday.

  • The news comes as Roche has faced scrutiny from the US over its planned $4.3-billion takeover of Spark Therapeutics.

  • "I feel confident that we have a strong pipeline that would support growth in the longer term," said Schwan.

  • "I don't think it's a wise strategy in the long term to fill a growth gap by M&A," the CEO remarked, adding "if you start filling gaps, you run the risk that you overpay or you take on board assets which do not fit strategically."

  • Schwan indicated that Roche now expects to complete the Spark deal by the end of the year.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.